LEKAPHARM A/S: Financial statements 2023
CVR: 32945945
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
LEKAPHARM A/S (CVR 32945945) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 3,450,083 and a net result of DKK 464,824 compared with DKK 4,591 the year before. That is an increase of 16.2% compared with the year before. Equity in the 2023 report amounted to DKK 6,403,568. The solvency ratio was 46.1%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 3,450,083
- Profit/Loss
- DKK 464,824
- Equity
- DKK 6,403,568
- Total Assets
- DKK 13,883,566
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 3.5 mio. | 465 t. | 6.4 mio. | 4 |
| 2022 | - | 3 mio. | 5 t. | 5.9 mio. | 5 |
| 2021 | - | 4.2 mio. | 459 t. | 6.4 mio. | 5 |
| 2020 | - | 3.6 mio. | 404 t. | 9.9 mio. | 3 |
| 2019 | - | 3.3 mio. | 633 t. | 10 mio. | 3 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
LEKAPHARM A/S has published its annual report for 2022. Gross profit came to DKK 2,968,088, and the net result was DKK 4,591.
About LEKAPHARM A/S
LEKAPHARM A/S is a Danish company of the type Aktieselskab based in Kværndrup, founded in 2010. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Lasse Kjeldsen. The board consists of Susanne Frederiksen (chair), Emil Bødker Kjeldsen and Lasse Kjeldsen. The company is owned by LKJ HOLDING 2010 ApS, CE-PHARMAMACHINERY ApS and Familien Kjeldsen Holding ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 10,369,416 and a net result of DKK 5,517,066 compared with DKK 2,051,529 the year before. Equity in the 2025 report amounted to DKK 7,972,163.